Article info
Review
Bremelanotide and flibanserin for low sexual desire in women: the fallacy of regulatory precedent
- Correspondence to Dr Barbara Mintzes, School of Pharmacy and Charles Perkins Centre, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia; barbara.mintzes{at}sydney.edu.au
Citation
Bremelanotide and flibanserin for low sexual desire in women: the fallacy of regulatory precedent
Publication history
- First published October 12, 2021.
Online issue publication
November 25, 2021
Article Versions
- Previous version (12 October 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.